Literature DB >> 9051360

Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells.

R K Dubey1, E K Jackson, H D Rupprecht, R B Sterzel.   

Abstract

The vasculature wall is an active, integrated organ composed of endothelial cells and vascular smooth muscle cells, as well as other cell types depending on the specific vascular segment (e.g. fibroblasts in many vascular regions). The vascular wall is not static; the vascular components (cells and extracellular matrix) dynamically increase, decrease or reorganize, or both, in response to physiological and pathological stimuli. The vascular smooth muscle cells are the final common pathway for many of these dynamic changes in vascular wall structure. In the renal glomerulus, however, the glomerular mesangial cells-a cell phenotypically related to the vascular smooth muscle cells-also participate. Although sometimes beneficial, changes in vascular or glomerular structure often lead to cardiovascular (e.g. atherosclerosis, restenosis, intimal hyperplasia) and renovascular (e.g. glomerulosclerosis) diseases. Consequently, much effort has been expended to elucidate the mechanisms that control growth and extracellular matrix production by vascular smooth muscle cells and glomerular mesangial cells. The purpose of this review is to discuss recent developments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051360     DOI: 10.1097/00041552-199701000-00016

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  15 in total

Review 1.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

2.  An organotypical in vitro model for vascular tissue remodelling and its application to study radiation effects.

Authors:  M Verbeke; H Thierens; Y Taeymans; L De Ridder
Journal:  Cytotechnology       Date:  2000-11       Impact factor: 2.058

Review 3.  Chronic nitric oxide inhibition model six years on.

Authors:  R Zatz; C Baylis
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

4.  Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.

Authors:  Edwin K Jackson; Stanton J Kochanek; Delbert G Gillespie
Journal:  Hypertension       Date:  2012-07-16       Impact factor: 10.190

5.  2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells.

Authors:  Lisa Rigassi; Federica Barchiesi Bozzolo; Eliana Lucchinetti; Michael Zaugg; Jürgen Fingerle; Marinella Rosselli; Bruno Imthurn; Edwin K Jackson; Raghvendra K Dubey
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

Review 6.  Regulation of matrix proteins and impact on vascular structure.

Authors:  J Tuñón; M Ruiz-Ortega; J Egido
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

7.  2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male Mice.

Authors:  Ajeeth K Pingili; Karen N Davidge; Shyamala Thirunavukkarasu; Nayaab S Khan; Akemi Katsurada; Dewan S A Majid; Frank J Gonzalez; L Gabriel Navar; Kafait U Malik
Journal:  Hypertension       Date:  2017-04-17       Impact factor: 10.190

8.  Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.

Authors:  Raghvendra K Dubey; Jürgen Fingerle; Delbert G Gillespie; Zaichuan Mi; Marinella Rosselli; Bruno Imthurn; Edwin K Jackson
Journal:  Hypertension       Date:  2015-09-28       Impact factor: 10.190

9.  Cytosolic phospholipase A2α regulates G1 progression through modulating FOXO1 activity.

Authors:  Said Movahedi Naini; Gabriel J Choukroun; James R Ryan; Dirk M Hentschel; Jagesh V Shah; Joseph V Bonventre
Journal:  FASEB J       Date:  2015-12-07       Impact factor: 5.191

10.  Association of glomerular filtration rate with arterial stiffness in Chinese women with normal to mildly impaired renal function.

Authors:  Su-Yan Bian; Hong-Yang Guo; Ping Ye; Lei-Ming Luo; Hong-Mei Wu; Wen-Kai Xiao; Li-Ping Qi; He-Peng Yu; Liu-Fa Duan
Journal:  J Geriatr Cardiol       Date:  2012-06       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.